Tuesday, November 21, 2017

Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis

Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - CSE New Listing - Choom Holdings Inc. (CHOO); @CSE_News

Investorideas.com - CSE New Listing - Choom Holdings Inc. (CHOO); @CSE_News

Get the latest Cannabis and Hemp stock news from www.investorideas.com

Investorideas.com - CannaSOS PerksCoin ICO is LIVE! 250,000 PCT Sold! Just 50,000 PerksCoins Remaining!

Investorideas.com - CannaSOS PerksCoin ICO is LIVE! 250,000 PCT Sold! Just 50,000 PerksCoins Remaining!

Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis

Investorideas.com - The Path to New Drug Discoveries and Development with #Cannabis



Stocks Mentioned: Veritas Pharma Inc. (CSE: $VRT.C;
OTC: $VRTHF), Zynerba (NASDAQ:  $ZYNE),
GW Pharmaceuticals
(NASDAQ:  $GWPH),
Tetra Bio-Pharma (TSXV:
$TBP.V; $TBPMF), Aphria Inc (TSX: $APH.TO; 
$APHQF)



Point Roberts, WA, November 21, 2017 –
Investorideas.com, a global news source and investor resource covering cannabis
and hemp stocks issues a sector news alert on companies with new drug
discoveries and developments in the sector.

Investorideas.com - #Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma

Investorideas.com - #Cannabis Stock News; Veritas' (CSE: $VRT.C) (OTC: $VRTHF) Research Division to Begin Human Trials of Its Lead #Cannabis Strain for Pain; @VeritasPharma



Research
Arm Cannevert Therapeutics Signs LOI with Fundación de Investigación of Puerto
Rico



Vancouver, B.C. - November 21, 2017
(Investorideas.com Newswire) Veritas Pharma Inc.- Cannabis and Biopharma News
alert -  (
CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), ("Veritas" or the
"Company") reports  that its research arm, Cannevert
Therapeutics Ltd. ("CTL") has signed a letter of intent with the
Fundación de Investigación (FDI) in San Juan, Puerto Rico, to conduct the first
human study of CTL-X, its lead cannabis strain targeting pain.